Tommaso Giani
About
Tommaso Giani is a scholar working on Molecular Medicine, Endocrinology and Clinical Biochemistry.
According to data from OpenAlex, Tommaso Giani has authored 99 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Medicine, 29 papers in Endocrinology and 28 papers in Clinical Biochemistry. Recurrent topics in Tommaso Giani's work include Antibiotic Resistance in Bacteria (83 papers), Bacterial Identification and Susceptibility Testing (28 papers) and Antibiotics Pharmacokinetics and Efficacy (24 papers). Tommaso Giani is often cited by papers focused on Antibiotic Resistance in Bacteria (83 papers), Bacterial Identification and Susceptibility Testing (28 papers) and Antibiotics Pharmacokinetics and Efficacy (24 papers). Tommaso Giani collaborates with scholars based in Italy, United States and Netherlands. Tommaso Giani's co-authors include Gian María Rossolini, Fabio Arena, Vincenzo Di Pilato, Marco Maria D’Andrea, Antonio Cannatelli, Viola Conte, Francesco Luzzaro, Simone Ambretti, Paolo Gaibani and Annalisa Pantosti and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.
In The Last Decade
Tommaso Giani
95 papers receiving 3.4k citations
Peers
Tommaso Giani
Ørjan Samuelsen Norway
Fabio Arena Italy
Francesco Luzzaro Italy
Gaëlle Cuzon France
Simona Bratu United States
Magdalena A. Taracila United States
Ângela Novais Portugal
J. Kamile Rasheed United States
Kenneth S. Thomson United States
Rémy A. Bonnin France
Citations per year, relative to Tommaso Giani Tommaso Giani (= 1×)
peers
Ørjan Samuelsen
Countries citing papers authored by Tommaso Giani
Since
Specialization
Citations
This map shows the geographic impact of Tommaso Giani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tommaso Giani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tommaso Giani more than expected).
Fields of papers citing papers by Tommaso Giani
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Tommaso Giani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tommaso Giani. The network helps show where Tommaso Giani may publish in the future.
Co-authorship network of co-authors of Tommaso Giani
This figure shows the co-authorship network connecting the top 25 collaborators of Tommaso Giani. A scholar is included among the top collaborators of Tommaso Giani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tommaso Giani. Tommaso Giani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Pelagatti, Lorenzo, Lorenzo Corbetta, Sara Tomassetti, et al.. (2025). Rapid testing with molecular syndromic panels of patients presenting at the emergency department with pneumonia at risk for multidrug-resistant pathogens. European Journal of Clinical Microbiology & Infectious Diseases. 45(3). 863–875.
2.
Antonelli, Alberto, et al.. (2025). Evaluation of QuickMIC system for rapid antimicrobial susceptibility testing of Gram-negative pathogens from positive blood cultures, including strains producing extended-spectrum β-lactamases and carbapenemases. Microbiology Spectrum. 13(7). e0037025–e0037025.
3.
Martone, Anna Maria, Iris Parrini, Francesca Ciciarello, et al.. (2024). Recent Advances and Future Directions in Syncope Management: A Comprehensive Narrative Review. Journal of Clinical Medicine. 13(3). 727–727.
4.
Antonelli, Alberto, et al.. (2024). Evaluation of the Vitek® Reveal™ system for rapid antimicrobial susceptibility testing of Gram-negative pathogens, including ESBL, CRE and CRAB, from positive blood cultures. Diagnostic Microbiology and Infectious Disease. 110(4). 116503–116503.
5.
Coppi, Marco, et al.. (2024). Evaluation of Quantamatrix dRASTTM system for rapid antimicrobial susceptibility testing of bacterial isolates from positive blood cultures, in comparison with commercial Micronaut broth microdilution system. Diagnostic Microbiology and Infectious Disease. 110(1). 116436–116436.
6.
Giacobbe, Daniele Roberto, Vincenzo Di Pilato, Ilias Karaiskos, et al.. (2023). Treatment and diagnosis of severe KPC-producing Klebsiella pneumoniae infections: a perspective on what has changed over last decades. Annals of Medicine. 55(1). 101–113.
7.
Debbio, Luigi Del, et al.. (2023). Inverse Problems in PDF determinations. Proceedings of The 39th International Symposium on Lattice Field Theory — PoS(LATTICE2022).
8.
Gaibani, Paolo, Tommaso Giani, Federica Bovo, et al.. (2022). Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing. Antibiotics. 11(5). 628–628.
9.
Khalek, Rabah Abdul, R. Gauld, Tommaso Giani, et al.. (2022). nNNPDF3.0: evidence for a modified partonic structure in heavy nuclei. The European Physical Journal C. 82(6).
10.
Morroni, Gianluca, Lucia Brescini, Alberto Antonelli, et al.. (2022). Clinical and microbiological features of ceftolozane/tazobactam-resistant Pseudomonas aeruginosa isolates in a university hospital in central Italy. Journal of Global Antimicrobial Resistance. 30. 377–383.
11.
Wong, Joshua L. C., Sophia David, Julia Sanchez‐Garrido, et al.. (2022). Recurrent emergence of Klebsiella pneumoniae carbapenem resistance mediated by an inhibitory ompK36 mRNA secondary structure. Proceedings of the National Academy of Sciences. 119(38). e2203593119–e2203593119.
12.
Coppi, Marco, Vincenzo Di Pilato, Francesco Monaco, et al.. (2020). Ceftazidime-Avibactam Resistance Associated with Increased bla KPC-3 Gene Copy Number Mediated by pKpQIL Plasmid Derivatives in Sequence Type 258 Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 64(4).
13.
Pilato, Vincenzo Di, Noemi Aiezza, Alberto Antonelli, et al.. (2020). KPC-53, a KPC-3 Variant of Clinical Origin Associated with Reduced Susceptibility to Ceftazidime-Avibactam. Antimicrobial Agents and Chemotherapy. 65(1).
14.
Mattiuz, Giorgio, Alberto Antonelli, Tommaso Giani, et al.. (2020). mcr-1 Gene Expression Modulates the Inflammatory Response of Human Macrophages to Escherichia coli. Infection and Immunity. 88(8).
15.
Parisio, Eva Maria, Marco Coppi, Claudia Niccolai, et al.. (2020). Evaluation of the commercial AD fosfomycin test for susceptibility testing of multidrug-resistant Enterobacterales and Pseudomonas aeruginosa. Clinical Microbiology and Infection. 27(5). 788.e5–788.e9.
16.
Giacobbe, Daniele Roberto, Tommaso Giani, Matteo Bassetti, et al.. (2019). Rapid microbiological tests for bloodstream infections due to multidrug resistant Gram-negative bacteria: therapeutic implications. Clinical Microbiology and Infection. 26(6). 713–722.
17.
Piccirilli, Alessandra, Mariagrazia Perilli, Gianfranco Amicosante, et al.. (2018). TEM-184, a Novel TEM-Derived Extended-Spectrum β-Lactamase with Enhanced Activity against Aztreonam. Antimicrobial Agents and Chemotherapy. 62(9).
18.
Giani, Tommaso, Antonio Cannatelli, Vincenzo Di Pilato, et al.. (2016). Inhibitory activity of avibactam against selected β-lactamases expressed in an isogenic Escherichia coli strain. Diagnostic Microbiology and Infectious Disease. 86(1). 83–85.
19.
Arena, Fabio, Tommaso Giani, Viola Conte, et al.. (2013). Large Oligoclonal Outbreak Due to Klebsiella pneumoniae ST14 and ST26 Producing the FOX-7 AmpC β-Lactamase in a Neonatal Intensive Care Unit. Journal of Clinical Microbiology. 51(12). 4067–4072.
20.
Luzzaro, Francesco, Gioconda Brigante, Marco Maria D’Andrea, et al.. (2008). Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type β-lactamase: epidemiology and clinical management. International Journal of Antimicrobial Agents. 33(4). 328–333.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Ørjan Samuelsen Breakdown of academic impact, for papers by Fabio Arena Breakdown of academic impact, for papers by Francesco Luzzaro Breakdown of academic impact, for papers by Gaëlle Cuzon Breakdown of academic impact, for papers by Simona Bratu Breakdown of academic impact, for papers by Magdalena A. Taracila Breakdown of academic impact, for papers by Ângela Novais Breakdown of academic impact, for papers by J. Kamile Rasheed Breakdown of academic impact, for papers by Kenneth S. Thomson Breakdown of academic impact, for papers by Rémy A. Bonnin